Ergomed (ERGO)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

 1,140.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,430.00
  • 52 Week Low: 555.00
  • Currency: UK Pounds
  • Shares Issued: 48.82m
  • Volume: 28,190
  • Market Cap: £556.53m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
65.33% above the market average65.33% above the market average65.33% above the market average65.33% above the market average65.33% above the market average
37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average
1yr Revenue Growth
70.54% above the market average70.54% above the market average70.54% above the market average70.54% above the market average70.54% above the market average
35.29% above the sector average35.29% above the sector average35.29% above the sector average35.29% above the sector average35.29% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
9.63% above the market average9.63% above the market average9.63% above the market average9.63% above the market average9.63% above the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average
Price Book Ratio
83.98% below the market average83.98% below the market average83.98% below the market average83.98% below the market average83.98% below the market average
63.27% below the sector average63.27% below the sector average63.27% below the sector average63.27% below the sector average63.27% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
53.85% below the market average53.85% below the market average53.85% below the market average53.85% below the market average53.85% below the market average
23.33% below the sector average23.33% below the sector average23.33% below the sector average23.33% below the sector average23.33% below the sector average
Price Chg 3m
11.07% below the market average11.07% below the market average11.07% below the market average11.07% below the market average11.07% below the market average
10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
11.75% below the market average11.75% below the market average11.75% below the market average11.75% below the market average11.75% below the market average
10.34% above the sector average10.34% above the sector average10.34% above the sector average10.34% above the sector average10.34% above the sector average
Momentum 20
97.18% below the market average97.18% below the market average97.18% below the market average97.18% below the market average97.18% below the market average
93.1% below the sector average93.1% below the sector average93.1% below the sector average93.1% below the sector average93.1% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
35.14% above the market average35.14% above the market average35.14% above the market average35.14% above the market average35.14% above the market average
56.76% above the sector average56.76% above the sector average56.76% above the sector average56.76% above the sector average56.76% above the sector average
ROCE
72.94% above the market average72.94% above the market average72.94% above the market average72.94% above the market average72.94% above the market average
47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
69.90% above the market average69.90% above the market average69.90% above the market average69.90% above the market average69.90% above the market average
76.00% above the sector average76.00% above the sector average76.00% above the sector average76.00% above the sector average76.00% above the sector average
Forecast EPS
33.77% above the market average33.77% above the market average33.77% above the market average33.77% above the market average33.77% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
26.11% above the market average26.11% above the market average26.11% above the market average26.11% above the market average26.11% above the market average
35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average
Operating Profit Loss
49.41% above the market average49.41% above the market average49.41% above the market average49.41% above the market average49.41% above the market average
69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
19.78% above the market average19.78% above the market average19.78% above the market average19.78% above the market average19.78% above the market average
26.53% above the sector average26.53% above the sector average26.53% above the sector average26.53% above the sector average26.53% above the sector average
Cash
21.11% above the market average21.11% above the market average21.11% above the market average21.11% above the market average21.11% above the market average
26.92% above the sector average26.92% above the sector average26.92% above the sector average26.92% above the sector average26.92% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
36.51% above the market average36.51% above the market average36.51% above the market average36.51% above the market average36.51% above the market average
Sector averageSector averageSector averageSector averageSector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Ergomed Market Data

Currency UK Pounds
Share Price 1,140.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,430.00
52 Week Low 555.00
Volume 28,190
Shares Issued 48.82m
Market Cap £556.53m

Ergomed Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.85% below the market average95.85% below the market average95.85% below the market average95.85% below the market average95.85% below the market average
88.46% below the sector average88.46% below the sector average88.46% below the sector average88.46% below the sector average88.46% below the sector average
Price Trend
70.48% above the market average70.48% above the market average70.48% above the market average70.48% above the market average70.48% above the market average
76.67% above the sector average76.67% above the sector average76.67% above the sector average76.67% above the sector average76.67% above the sector average
Income Not Available
Growth
91.46% above the market average91.46% above the market average91.46% above the market average91.46% above the market average91.46% above the market average
88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Ergomed Dividends

No dividends found

Trades for 27-Jul-2021

Time Volume / Share Price
12:10 1,500 @ 1,155.80p
11:42 42 @ 1,140.00p
11:38 1 @ 1,135.80p
11:37 96 @ 1,140.00p
11:33 97 @ 1,140.00p

Ergomed Key Personnel

CFO Richard Barfield

Top of Page